Elanco Animal Health Incorporated (ELAN): Price and Financial Metrics
GET POWR RATINGS... FREE!
ELAN POWR Grades
- Growth is the dimension where ELAN ranks best; there it ranks ahead of 90.52% of US stocks.
- ELAN's strongest trending metric is Momentum; it's been moving down over the last 179 days.
- ELAN's current lowest rank is in the Momentum metric (where it is better than 14.48% of US stocks).
ELAN Stock Summary
- ELAN has a higher market value than 83.7% of US stocks; more precisely, its current market capitalization is $13,026,831,283.
- ELAN's went public 3.53 years ago, making it older than merely 11.65% of listed US stocks we're tracking.
- As for revenue growth, note that ELAN's revenue has grown 45.57% over the past 12 months; that beats the revenue growth of 79.71% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Elanco Animal Health Inc are HAS, XRX, CCMP, WAB, and AGFS.
- Visit ELAN's SEC page to see the company's official filings. To visit the company's web site, go to www.elanco.com.
ELAN Valuation Summary
- ELAN's price/earnings ratio is -21.7; this is 159.45% lower than that of the median Healthcare stock.
- Over the past 36 months, ELAN's EV/EBIT ratio has gone up 19.
- Over the past 36 months, ELAN's EV/EBIT ratio has gone up 19.
Below are key valuation metrics over time for ELAN.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| ELAN | 2021-08-31 | 3.5 | 2.0 | -21.7 | -34.7 |
| ELAN | 2021-08-30 | 3.5 | 2.0 | -21.7 | -34.8 |
| ELAN | 2021-08-27 | 3.5 | 2.0 | -21.6 | -34.7 |
| ELAN | 2021-08-26 | 3.4 | 1.9 | -21.3 | -34.3 |
| ELAN | 2021-08-25 | 3.4 | 1.9 | -21.2 | -34.1 |
| ELAN | 2021-08-24 | 3.4 | 1.9 | -21.0 | -33.9 |
ELAN's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- ELAN has a Quality Grade of D, ranking ahead of 16.1% of graded US stocks.
- ELAN's asset turnover comes in at 0.265 -- ranking 169th of 682 Pharmaceutical Products stocks.
- 500 - Internal server error
The table below shows ELAN's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.265 | 0.526 | -0.072 |
| 2021-03-31 | 0.250 | 0.507 | -0.065 |
| 2020-12-31 | 0.240 | 0.491 | -0.081 |
| 2020-09-30 | 0.255 | 0.493 | -0.046 |
| 2020-06-30 | 0.300 | 0.501 | -0.018 |
| 2020-03-31 | 0.329 | 0.513 | 0.009 |
ELAN Stock Price Chart Interactive Chart >
ELAN Price/Volume Stats
| Current price | $20.62 | 52-week high | $37.49 |
| Prev. close | $19.63 | 52-week low | $19.34 |
| Day low | $19.55 | Volume | 6,338,400 |
| Day high | $20.66 | Avg. volume | 4,769,901 |
| 50-day MA | $22.96 | Dividend yield | N/A |
| 200-day MA | $27.42 | Market Cap | 9.78B |
Elanco Animal Health Incorporated (ELAN) Company Bio
Elanco Animal Health Incorporated operates as an animal health care company. The Company develops, manufactures, and markets products for companion and food animals. Elanco Animal Health serves clients worldwide. The company is based in Greenfield, Indiana.
Latest ELAN News From Around the Web
Below are the latest news stories about Elanco Animal Health Inc that investors may wish to consider to help them evaluate ELAN as an investment opportunity.
10 Companies That Topped Profit ExpectationsIn this article, we will take a look at the 10 companies that topped profit expectations. You can skip our detailed analysis of these companies and go directly to the 5 Companies That Topped Profit Expectations. Notable stocks from the consumer cyclical sector, including Booking Holdings Inc. (NASDAQ:BKNG), eBay Inc. (NASDAQ:EBAY) and Bath & Body […] |
Elanco Animal Health Incorporated (ELAN) CEO Jeff Simmons on Q4 2021 Results - Earnings Call TranscriptElanco Animal Health Incorporated (ELAN) Q4 2021 Earnings Conference Call February 24, 2022 08:30 AM ET Company Participants Katy Grissom - Head of IR Jeff Simmons - CEO Todd Young - CFO Ellen de Brabander - EVP of Innovation and Regulatory Affairs Scott Purucker - IR Conference Call Participants Erin... |
Elanco Animal Health''s Q4 Earnings Beat Expectation, FY22 Sales Guidance Trail EstimatesElanco Animal Health Inc (NYSE: ELAN ) has reported Q4 EPS of $0.21 higher than $0.12 reported a year ago, surpassing analysts'' view of $0.17. Revenue was $1.11 billion, a decrease of 2% YY, unfavorably impacted by approximately $60 million of previously disclosed items that benefited Q4 FY20., beating the consensus of $1.10 billion. Pet Health''s revenue decreased 1% and was flat when excluding … Full story available on Benzinga.com |
Elanco Animal Health Reports Fourth Quarter and Full Year 2021 ResultsGREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported its financial results for the fourth quarter and full year 2021, and provided initial guidance both for the first quarter and full year 2022. “2021 was a historic year for Elanco as we completed our independent company standup, continued our integration of Bayer Animal Health and recorded our highest revenue and adjusted EBITDA levels as a public company. We grew revenue 7 percent compared to our 20 |
Elanco Animal Health Incorporated 2021 Q4 - Results - Earnings Call PresentationNo summary available. |
ELAN Price Returns
| 1-mo | -14.76% |
| 3-mo | -20.63% |
| 6-mo | -26.09% |
| 1-year | -40.98% |
| 3-year | -39.69% |
| 5-year | N/A |
| YTD | -27.34% |
| 2021 | -7.47% |
| 2020 | 4.14% |
| 2019 | -6.60% |
| 2018 | N/A |
| 2017 | N/A |
Continue Researching ELAN
Want to see what other sources are saying about Elanco Animal Health Inc's financials and stock price? Try the links below:Elanco Animal Health Inc (ELAN) Stock Price | Nasdaq
Elanco Animal Health Inc (ELAN) Stock Quote, History and News - Yahoo Finance
Elanco Animal Health Inc (ELAN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...